SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (170)2/22/1999 6:33:00 PM
From: mike head  Respond to of 3158
 
Peter. The current issue (Vol.17) of Nature Biotech, has a supplement called 'bioentrepreneurship.In it are a number of articles addressing essentially what has be discussed on this thread! It's a good read (does require free registration which is good for all Nature sites). Try:
biotech.nature.com
pax et bonum, mch



To: Biomaven who wrote (170)2/22/1999 9:19:00 PM
From: LLCF  Read Replies (2) | Respond to of 3158
 
<Headline: Biogen Announces That Board of Directors has Authorized Repurchase of Up to 4,000,000 Shares of Common Stock>

Well, hell theres just nothing around worth buying! Just ask their investment banker, he should know. :{

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News